Results 41 to 50 of about 578 (125)

Evaluating swine disease occurrence on farms using the state-space model based on meat inspection data: a time-series analysis. [PDF]

Porcine Health Manag
Narita T, Kubo M, Nagakura Y, Sekiguchi S.   +3 more
europepmc   +1 more source

Evaluation of alternative antimicrobial strategies in high-performance pigs for managing endemic Mycoplasma hyopneumoniae populations. [PDF]

Trop Anim Health Prod
Nagae RY, Barcellos DESN, Takeuti KL, Mellagi APG, Cé TRM, Cavazinni N, Kunrath C, Scher A, Wolf J, Bortolozzo FP, Ulguim RDR.   +10 more
europepmc   +1 more source

Association of swine leukocyte antigen class II haplotypes and immune-related traits in a swine line selected for resistance to mycoplasmal pneumonia

Association of swine leukocyte antigen class II haplotypes and immune-related traits in a swine line selected for resistance to mycoplasmal pneumonia
By selective breeding for five generations, a Landrace line has been recently established to improve resistance to mycoplasmal pneumonia of swine (MPS), daily gain (DG), back fat thickness (BF), and plasma cortisol concentrations (COR). To clarify the involvement of swine leukocyte antigen (SLA) polymorphisms in the selection process, we investigated ...
openaire  

Respiratory microbiota dynamics in piglets under nanotechnology-based and conventional vaccination protocols against Mycoplasma hyopneumoniae. [PDF]

BMC Vet Res
de Oliveira LG, Lopes Mechler-Dreibi M, Storino GY, Moreira Petri FA, Carvalho Abreu Fantini M, Silva Martins T.   +5 more
europepmc   +1 more source

Identification of Nonsynonymous SNPs in Immune-Related Genes Associated with Pneumonia Severity in Pigs. [PDF]

Genes (Basel)
Shinkai H, Suzuki K, Itoh T, Yoshioka G, Takenouchi T, Kitazawa H, Uenishi H.   +6 more
europepmc   +1 more source

Comparative field efficacy of all-in-one intradermal vaccine based on an inactivated recombinant <i>Mycoplasma hyopneumoniae</i> with an embedded/integrated porcine circovirus type 2 (PCV2) capsid protein and concurrent administration with monovalent of <i>M. hyopneumoniae</i> and PCV2 intradermal vaccine. [PDF]

Front Vet Sci
Suh J, Ham S, Chae C.
europepmc   +1 more source

Prevalence and Risk Factors of Mycoplasma Hyopneumoniae in Swine Farms, Mainland China, 2003-2024: A Meta-Analysis. [PDF]

Vet Sci
Zhou H, Zhang H, Zhang X, Ye L, Liu X, Zhang T.   +5 more
europepmc   +1 more source

Tylvalosin tartrate inhibits PRRSV replication by suppressing cellular pyroptosis through the TLR4/NF-κB signaling pathway. [PDF]

J Virol
Zhang S-q, Li X-l, Yang C, Li D-w, Deng X-h, Hu W, Pei X-y, Zhang W-j, Yu X-x, Sun Y-F.   +9 more
europepmc   +1 more source

CD40 Ligand Potentiates Immunogenecity of Mycoplasma pneumoniae Subunit Vaccine Candidate in a Murine Model. [PDF]

Curr Issues Mol Biol
Shu J, Li G, Shu J, Feng H, He Y.
europepmc   +1 more source

Non-Compromised Efficacy of the First Commercial Ready-to-Use Genotype 2d Porcine Circovirus Type 2 and <i>Mycoplasma hyopneumoniae</i> Vaccine. [PDF]

Viruses
Pálmai N, Széplaki NÁ, Molnár B, Smits H, Krejci R, Kiss I.   +5 more
europepmc   +1 more source